Sciencast Management’s CONMED CNMD Stock Holding History

Sciencast Management’s Portfolio CNMD Stock Details CNMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	$522K	Buy	+5,328	New	+$639K	0.12%	248
2022 Q1	–	Sell	-1,628	Closed	-$243K	–	575
2021 Q4	$243K	Buy	+1,628	New	+$231K	0.04%	411
2021 Q1	–	Sell	-3,313	Closed	-$386K	–	514
2020 Q4	$386K	Buy	+3,313	New	+$314K	0.08%	312
2019 Q3	–	Sell	-2,400	Closed	-$202K	–	375
2019 Q2	$202K	Buy	+2,400	New	+$197K	0.11%	267

Other funds holding CNMD

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $3.89B AUM 16.15% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Sciencast Management's CNMD Position: Q2 2022 in Review

Sciencast Management opened a new position in CONMED (CNMD) in Q2 2022: 5,328 shares worth $522K. The stake represents 0.12% of the portfolio and ranks #248 among its holdings. This is a return to the name: Sciencast Management previously reported a position in CNMD as recently as Q4 2021.

Sciencast Management first reported a position in CNMD in Q2 2019 and has held it in 4 quarters since. 279 funds tracked by Wall St. Rank hold CNMD as of Q2 2022.

Sciencast Management held 5,328 shares of CONMED worth $522K as of Q2 2022.
CONMED was a new Sciencast Management position in Q2 2022.
CONMED made up 0.12% of Sciencast Management's portfolio in Q2 2022, its #248 holding.
Sciencast Management first reported a position in CONMED in Q2 2019 and has held it in 4 quarters since.
279 funds tracked by Wall St. Rank held CONMED as of Q2 2022.

Based on Sciencast Management's 13F filing for Q2 2022, filed 3 Aug 2022.